Lipocine (NASDAQ:LPCN) Coverage Initiated at StockNews.com
Stock analysts at StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Get Free Report) in a report issued on Thursday. The firm set a “hold” rating on the specialty pharmaceutical company’s stock. Lipocine Price Performance Shares of NASDAQ:LPCN opened at $3.44 on Thursday. The firm’s 50 day moving average price is $4.11 and its […]
